EBAA Comments on FDA Guidances
EBAA submitted comments to FDA last week on recent guidances that address HCT/P donor eligibility and recommendations to reduce the risk of HIV, hepatitis B virus and hepatitis C virus […]
National Women Physicians Day
February 3 is National Women Physicians Day. The date celebrates Elizabeth Blackwell’s birthday – the first female medical doctor in the U.S., and is a time to honor women doctors […]
FDA Revises Implementation Dates for Sepsis and Mtb Guidances
The FDA has announced a revised implementation date of May 4, 2025, for its recently issued guidance documents: While the guidance documents remain final, FDA’s decision to delay implementation reflects a […]
Quick Analysis of HCT/P Guidance Documents
Recommendations to Reduce the Risk of Transmission of Disease Agents Associated with Sepsis by HCT/Ps Recommendations to Reduce the Risk of Transmission of Mycobacterium tuberculosis (Mtb) by Human Cells, Tissues, […]
Regulatory Alert: FDA Releases HCT/P Guidance Documents
FDA released four draft and two final tissue guidances on January 6, 2025, for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). EBAA will be hard at […]
DRAI Alert
Release of Updated Uniform DRAI Forms A fully updated Birth Mother Uniform Donor Risk Assessment Interview (DRAI) has been released for use when the donor is less than 18 months […]
Happy Holidays from EBAA!
During this season of gratitude and reflection, the EBAA staff sends our deepest appreciation to you for your ongoing dedication to the restoration of sight worldwide! As you celebrate the […]
